New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC

Publisher： Bentham Science Publishers

E-ISSN： 2212-389x|6|2|260-266

ISSN： 1574-3624

Source： Current Signal Transduction Therapy, Vol.6, Iss.2, 2011-05, pp. : 260-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Organ-Specific Pharmacological Strategies Interfering With Signaling Pathways In Inflammatory Disorders/Autoimmune Disorders

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 279-291

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Towards Tailored Treatment - New Organ-Specific Drug Strategies Interfering in Signal Transduction (Guest Editors: Jai Prakash and Martin H. de Borst)]

By  

Current Signal Transduction Therapy, Vol. 6, Iss. 2, 2011-05 ,pp. : 234-236

Bentham Science Publishers

Access to resources Recommend Favorite

Immune checkpoint inhibitors: new strategies to checkmate cancer

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 2, 2018-02 ,pp. : 133-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks

By Tomioka Haruaki   Tatano Yutaka   Sano Chiaki   Shimizu Toshiaki  

Journal of Infection and Chemotherapy, Vol. 17, Iss. 3, 2011-06 ,pp. : 302-317

Springer Publishing Company

Access to resources Recommend Favorite

New HIV protease inhibitors for drug-resistant viruses

By Rusconi Stefano   Viganòò Ottavia  

Therapy, Vol. 3, Iss. 1, 2006-01 ,pp. : 79-88

Future Medicine

Access to resources Recommend Favorite